Cue Biopharma Inc.
CUE | NASDAQ
$29.11
+$0.84 (+2.97%)
Sep 22, 2026, 10:25 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 27.47M | 9.29M | 5.49M | 1.25M | 14.94M | 3.15M |
Cost of Revenue | n/a | n/a | 38.1M | n/a | -1.78M | 33.55M |
Gross Profit | 27.47M | 9.29M | -32.61M | 1.25M | 16.72M | -30.39M |
Operating Income | -26.52M | -41.5M | -52.15M | -53.23M | -43.71M | -45.04M |
Interest Income | 807K | 1.62M | 2.66M | 928.24K | 45.9K | 463.91K |
Pretax Income | -26.1M | -40.67M | -50.73M | -53.01M | -43.67M | -44.58M |
Net Income | -26.6M | -40.67M | -50.73M | -53.01M | -44.16M | -44.78M |
Selling & General & Admin | 16.24M | 14.59M | 16.68M | 16.17M | 17.31M | 14.65M |
Research & Development | 37.74M | 36.3M | 40.8M | 38.58M | 41.35M | 33.55M |
Other Expenses | n/a | -93K | -37.94M | -277K | 1.78M | -33.55M |
Operating Expenses | 53.99M | 50.79M | 19.54M | 54.47M | 60.43M | 14.65M |
Interest Expense | 357K | 796K | 1.25M | 713.82K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 53.99M | 50.79M | 57.64M | 54.47M | 58.65M | 48.2M |
Income Tax Expense | 500K | n/a | n/a | n/a | 495K | 206.25K |
Shares Outstanding (Basic) | 3.16M | 1.88M | 1.53M | 1.19M | 1.04M | 956.29K |
Shares Outstanding (Diluted) | 3.16M | 1.88M | 1.53M | 1.19M | 1.04M | 956.29K |
EPS (Basic) | -8.40 | -21.60 | -33.30 | -44.70 | -42.30 | -46.80 |
EPS (Diluted) | -8.40 | -21.60 | -33.30 | -44.70 | -42.30 | -46.80 |
EBITDA | -22.27M | -37.53M | -46.05M | -50.49M | -45.44M | -43.99M |
EBIT | -25.75M | -39.88M | -49.49M | -52.3M | -43.67M | -45.04M |
Depreciation & Amortization | 3.48M | 2.35M | 3.44M | 1.81M | -1.78M | 1.06M |
Add to Watchlist
Select watchlists to add or remove CUE